Publication | Closed Access

KRN951, a highly potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, has antitumor activities and affects functional vascular properties

AngiogenesisAntitumor ActivitiesPotent InhibitorMedicineVascular PharmacologyEndothelial DysfunctionReceptor Tyrosine KinaseVascular BiologyPharmacologyCell BiologyCell SignalingTumor MicroenvironmentTumor BiologyFunctional Vascular Properties